Mason Carrico
Stock Analyst at Stephens & Co.
(0.28)
# 2103
Out of 5,234 analysts
59
Total ratings
52.08%
Success rate
6.49%
Average return
Main Sectors:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Castle Biosciences | Reiterates: Overweight | 41 41 | 29.24 | 40.22% | 7 | Jan 2, 2025 | |
Illumina | Maintains: Overweight | 170 184 | 138.53 | 32.82% | 6 | Nov 12, 2024 | |
10x Genomics | Reiterates: Overweight | 30 30 | n/a | n/a | 5 | Oct 10, 2024 | |
Pacific Biosciences | Maintains: Overweight | 4 3 | 2 | 25% | 2 | Aug 13, 2024 | |
Natera | Reiterates: Overweight | 125 125 | 172.15 | -27.39% | 4 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 92 92 | 73.72 | 24.8% | 2 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 19 19 | n/a | n/a | 1 | Jul 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 44 44 | 35.8 | 22.91% | 4 | May 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 15 18 | 23.23 | -22.51% | 8 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 2 2 | n/a | n/a | 4 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 4 | 2.28 | 75.44% | 3 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 9 | 6.77 | 32.94% | 1 | Dec 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 14 9 | 2.45 | 267.35% | 4 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 34 | 43.41 | -21.68% | 5 | Oct 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 24 | 13.73 | 74.8% | 3 | May 4, 2023 |